|
CSGALNACT2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.923200E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.923100E-03 |
| Normal-vs-Stage2 |
2.464400E-01 |
| Normal-vs-Stage3 |
1.108360E-01 |
| Normal-vs-Stage4 |
7.417600E-01 |
| Stage1-vs-Stage2 |
2.350600E-01 |
| Stage1-vs-Stage3 |
3.345800E-01 |
| Stage1-vs-Stage4 |
1.776440E-01 |
| Stage2-vs-Stage3 |
7.843800E-01 |
| Stage2-vs-Stage4 |
7.229200E-01 |
| Stage3-vs-Stage4 |
5.545200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.795500E-03 |
| Normal-vs-AfricanAmerican |
3.846500E-02 |
| Normal-vs-Asian |
8.596600E-01 |
| Caucasian-vs-AfricanAmerican |
4.971800E-01 |
| Caucasian-vs-Asian |
1.410200E-01 |
| AfricanAmerican-vs-Asian |
2.816200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.170200E-04 |
| Normal-vs-Female |
9.774400E-01 |
| Male-vs-Female |
1.608480E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.439500E-03 |
| Normal-vs-Extreme_Weight |
3.039900E-04 |
| Normal-vs-Obese |
1.153410E-01 |
| Normal-vs-Extreme_Obese |
1.078290E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.283200E-01 |
| Normal_Weight-vs-Obese |
2.112200E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.197000E-01 |
| Extreme_Weight-vs-Obese |
5.380400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.921800E-01 |
| Obese-vs-Extreme_Obese |
9.173900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.641800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.596000E-02 |
| Normal-vs-Age(61-80Yrs) |
2.415500E-03 |
| Normal-vs-Age(81-100Yrs) |
5.036600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.528000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.103900E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.352500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.395840E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.842370E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.630000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.179800E-04 |
| Normal-VS-Type2 PRCC |
1.298370E-03 |
| Normal-VS-KIRP CIMP |
1.631800E-01 |
| Normal-VS-Unclassified PRCC |
9.183600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
8.002200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
5.99449999999502E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.979600E-02 |
| Type2 PRCC-VS-KIRP CIMP |
2.438800E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
1.960280E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.646780E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.756400E-04 |
| Normal-vs-N1 |
9.954800E-01 |
| Normal-vs-N2 |
7.267000E-01 |
| N0-vs-N1 |
3.584100E-03 |
| N0-vs-N2 |
2.921600E-01 |
| N1-vs-N2 |
6.403800E-01 |
|
|
